Skip to main content
Fig. 1 | Trials

Fig. 1

From: Comparison of the clinical performance of the flexible laryngeal mask airway in pediatric patients under general anesthesia with or without a muscle relaxant: study protocol for a randomized controlled trial

Fig. 1

SPIRIT flow diagram: schedule of enrollment, interventions, and assessments. *Including mean blood pressure and heart rate, † Including ventilator parameter changes such as peak inspiratory pressure (PIP) and expiratory tidal volume to set tidal volume ratio (TVe/TVs) before and at the end of surgery, ‡including respiratory adverse events (coughing, laryngospasm, bronchospasm, postoperative stridor, and desaturation; SpO2 <95%), gastric insufflation, excessive secretion, postoperative nausea and vomiting, sore throat and bloody tinge on the LMA surface; T1 at preoperative waiting area, T2 after the loss of consciousness is achieved, T3 insertion of LMA, T4 cessation of anesthetics, T5 extubation, T6 PACU arrival, T7 PACU discharge. mYPAS modified Yale Preoperative Anxiety Scale, BIS bispectral index, ETsevo % end-tidal sevoflurane concentration, TOF train of four, OLP oropharyngeal leak pressure, FOB fiberoptic bronchoscopy, FLACC Face, Legs, Activity, Cry, and Consolability

Back to article page

Trials

ISSN: 1745-6215